Peptide receptor radionuclide therapy (Lu-177 PRRT) in neuroendocrine tumors (NET): Single institution experience over 15 years.
Year: 2025
Type: article
Study design: Observational Study
Source: Journal of Clinical Oncology
Authors: Ali H Aljubran, Ahmed Almuhaideb, Hussein Raef, Abdullah Almehaidib, Ahmed Ali Badran, Tusneem Elhassan, Shaikhah Alharbi, Mahmoud Abdelsatar Elshenawy
Institution: King Faisal Specialist Hospital & Research Centre
Language: English
Subfield: Epidemiology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4410813272